Literature DB >> 21644140

Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease.

David Aaron Maroof1, Alden L Gross, Jason Brandt.   

Abstract

Persons who have the genetic mutation responsible for Huntington's disease (HD) have been shown to exhibit lower cognitive test scores years prior to manifest HD. Most studies have examined cognitive performance in presymptomatic persons by using estimated times to manifest HD based on published algorithms. We followed 19 gene-positive persons who were presymptomatic using an objective criterion (i.e., Quantified Neurological Exam score ≤ 10) at baseline for up to 21 years (median = 5 years) with periannual neuropsychological assessments until a diagnosis of manifest HD. Results showed that our tests of information- and psychomotor-processing speed that place minimal demands on cognition, worsening performance became evident 5-10 years prior to the development of manifest HD. In conclusion, cognitive decline precedes motor signs in HD and may be an important target in clinical trials and early intervention. Cognitive test scores may also improve the ability to predict disease onset among gene mutation carriers and help families to better plan for potential personal and economic hardship.

Entities:  

Mesh:

Year:  2011        PMID: 21644140     DOI: 10.1080/13803395.2011.574606

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  10 in total

1.  Movement sequencing in Huntington disease.

Authors:  Nellie Georgiou-Karistianis; Jeffrey D Long; Spencer G Lourens; Julie C Stout; James A Mills; Jane S Paulsen
Journal:  World J Biol Psychiatry       Date:  2014-03-28       Impact factor: 4.132

2.  Feasibility and initial validation of 'HD-Mobile', a smartphone application for remote self-administration of performance-based cognitive measures in Huntington's disease.

Authors:  Brendan McLaren; Sophie C Andrews; Yifat Glikmann-Johnston; Emily-Clare Mercieca; Nicholas W G Murray; Clement Loy; Mark A Bellgrove; Julie C Stout
Journal:  J Neurol       Date:  2020-09-03       Impact factor: 4.849

3.  HDQLIFE and neuro-QoL physical function measures: Responsiveness in persons with huntington's disease.

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Kelvin L Chou; Rebecca E Ready; David Cella; Michael K McCormack; Jennifer A Miner; Praveen Dayalu
Journal:  Mov Disord       Date:  2019-11-14       Impact factor: 10.338

Review 4.  Statistical Approaches to Longitudinal Data Analysis in Neurodegenerative Diseases: Huntington's Disease as a Model.

Authors:  Tanya P Garcia; Karen Marder
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

5.  Responsiveness to Change Over Time: An Examination of the Neuro-QoL Social Function Measures in Persons with Huntington's Disease.

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Elizabeth A Hahn; Stacey K Barton; David Cella; Michael K McCormack; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2020

6.  Cognitive decline in prodromal Huntington Disease: implications for clinical trials.

Authors:  Jane S Paulsen; Megan M Smith; Jeffrey D Long
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-02       Impact factor: 10.154

7.  A retrospective analysis of hand tapping as a longitudinal marker of disease progression in Huntington's disease.

Authors:  Lucy M Collins; Stanley E Lazic; Roger A Barker
Journal:  BMC Neurol       Date:  2014-02-24       Impact factor: 2.474

8.  Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.

Authors:  Jane S Paulsen; Jeffrey D Long; Hans J Johnson; Elizabeth H Aylward; Christopher A Ross; Janet K Williams; Martha A Nance; Cheryl J Erwin; Holly J Westervelt; Deborah L Harrington; H Jeremy Bockholt; Ying Zhang; Elizabeth A McCusker; Edmond M Chiu; Peter K Panegyres
Journal:  Front Aging Neurosci       Date:  2014-04-22       Impact factor: 5.750

9.  Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Matthew W Roché; Rebecca E Ready; Joel S Perlmutter; Kelvin L Chou; Stacey K Barton; Michael K McCormack; Julie C Stout; David Cella; Jennifer A Miner; Jane S Paulsen
Journal:  Qual Life Res       Date:  2020-08-19       Impact factor: 4.147

10.  Normative Data for the Symbol Digit Modalities Test in Older White Australians and Americans, African-Americans, and Hispanic/Latinos.

Authors:  Joanne Ryan; Robyn L Woods; Carlene J Britt; Anne M Murray; Raj C Shah; Christopher M Reid; Rory Wolfe; Mark R Nelson; Suzanne G Orchard; Jessica E Lockery; Ruth E Trevaks; Elsdon Storey
Journal:  J Alzheimers Dis Rep       Date:  2020-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.